World Health Organization Says CBD Has Not Contributed to Any Public Health Problems

Here in the United States, the federal government has taken a hard zero-tolerance policy when it comes to marijuana. But it turns out the UN has a much more rational approach on the issue.

The World Health Organization (WHO) released a preliminary report on cannabidiol (CBD), a cannabinoid that is found in marijuana, and whether it contributes to public health problems. The report said that CBD is "not associated with abuse potential" and does not lead to physical dependence. They also said, “CBD is generally well tolerated with a good safety profile."

WHO's report also mentioned how this differs from CBD's classification by the U.S. government, which says that marijuana and all its derivatives are Schedule I narcotics, meaning they have "high potential of abuse."

The report went on to say that CBD has been "demonstrated as an effective treatment for epilepsy" and that "preliminary evidence that CBD may be a useful treatment for a number of other medical conditions." 

WHO concluded their report by saying, “[T]here is no evidence of recreational use of CBD or any public health related problems associated with the use of pure CBD.”

So basically an organization whose job it is to protect public health around the world has stated that CBD carries no risks and there's significant evidence that it can be used to treat a number of medical conditions.

So who are you going to trust? The world's leading doctors and medical researchers, or our Attorney General from Alabama with no background in medicine? The answer is clear.

(h/t NORML)


With so much buzz around the expansion of the cannabis industry, a number of heavy-weight investors and brands are making headway in the space. Civilized teamed up with Thomas George, stock expert and president of Grizzle, at Grit Island Investment Conference in the Bahamas to learn about what's next for cannabis, what investors are looking for, international opportunities, and developing interest in auxiliary industries like CBD. We also got the 411 on cannabis titan Aurora's latest acquisitions, as well as on New York's proposed adult use marijuana program.

Can we see some ID please?

You must be 19 years of age or older to enter.